PRECIGEN
Precigen is a biotechnology company that develops synthetic biology solutions. The company designs, builds, and regulates gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
PRECIGEN
Industry:
Biotechnology Life Science Medical Therapeutics
Founded:
1998-01-01
Address:
Germantown, Maryland, United States
Country:
United States
Website Url:
http://www.precigen.com
Total Employee:
101+
Status:
Active
Contact:
15409610734
Email Addresses:
[email protected]
Total Funding:
630.8 M USD
Technology used in webpage:
Domain Not Resolving DNSSEC Microsoft Apple Whitelist ASP.NET 2.0 Klarna
Similar Organizations
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Proteostasis Therapeutics
Proteostasis Therapeutics is a clinical stage biopharmaceutical company developing small molecule therapeutics to treat cystic fibrosis.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2017-01-24 | GenVec | GenVec acquired by Precigen | N/A |
| 2016-02-25 | EnviroFlight | EnviroFlight acquired by Precigen | N/A |
| 2015-08-10 | Oxitec | Oxitec acquired by Precigen | 160 M USD |
| 2015-02-13 | ActoGeniX | ActoGeniX acquired by Precigen | 60 M USD |
| 2013-12-20 | Medistem | Medistem acquired by Precigen | N/A |
| 2011-10-24 | Immunologix | Immunologix acquired by Precigen | N/A |
| 2011-02-02 | Agarigen, Inc | Agarigen, Inc acquired by Precigen | N/A |
Investors List
Randal J. Kirk
Randal J. Kirk investment in Series F - Precigen
Third Security
Third Security investment in Series F - Precigen
Randal J. Kirk
Randal J. Kirk investment in Series E - Precigen
NewVa Capital Partners
NewVa Capital Partners investment in Series E - Precigen
Third Security
Third Security investment in Series E - Precigen
Third Security
Third Security investment in Series C - Precigen
NewVa Capital Partners
NewVa Capital Partners investment in Venture Round - Precigen
Third Security
Third Security investment in Series B - Precigen
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2014-12-02 | Histogenics | Precigen investment in Post-IPO Equity - Histogenics | 70 M USD |
Key Employee Changes
Official Site Inspections
http://www.precigen.com Semrush global rank: 4.42 M Semrush visits lastest month: 2.35 K
- Host name: 174.60.185.35.bc.googleusercontent.com
- IP address: 35.185.60.174
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Precigen"
Precigen - Wikipedia
Precigen, Inc. (formerly Intrexon Corporation, NASDAQ: PGEN) is an American biotechnology company. Its president and CEO is Helen Sabzevari. Intrexon was founded in 1998, and is …See details»
About - Precigen
Precigen’s mission is to discover, develop and commercialize next generation gene and cell therapies focused in immuno-oncology, autoimmune disorders, and infectious diseases.See details»
Governance - Precigen
Governance Press & Events Stock Financials Governance Resources Governance Documents Committee Charters IRS Form 8937 Related to Name Change from Intrexon to Precigen IRS …See details»
After 27 years Precigen gets an approval | ApexOnco - Clinical …
6 days ago Precigen, the company formerly known as Intrexon, has scored its first approval after a 27-year existence. The FDA nod, received on Friday, isn't for one of the Car-T therapies for …See details»
Precigen Org Chart + Executive Team - The Official Board
The org chart of Precigen contains its 81 main executives like Helen Sabzevari, Harry Thomasian and Rutul Shah.See details»
Precigen - Crunchbase Company Profile & Funding
Precigen is a life sciences company researching and developing bio-therapeutic control systems to minimize toxicity.See details»
Precigen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Our commercial organization has been working to scale up quickly, right-sizing the organization to rapidly capitalize on the immense demand from patients and treating …See details»
Precigen, Inc. - AnnualReports.com
Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell …See details»
Precigen Company Profile - Office Locations, Competitors ... - Craft
Oct 29, 2024 Precigen has 1 employees across 3 locations and $26.91 m in annual revenue in FY 2022. See insights on Precigen including office locations, competitors, revenue, financials, …See details»
Precigen | LinkedIn
Precigen: Advancing Medicine with Precision™ Precigen (Nasdaq: PGEN) is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of …See details»
Precigen Inc Company Profile - Overview - GlobalData
Precigen Inc: Overview Precigen Inc (Precigen) is a clinical-stage biopharmaceutical company that carries out the discovery and development of gene and cell therapies. The company's …See details»
Precigen - VentureRadar
"Precigen is a dedicated discovery and clinical stage biopharmaceutical company advancing the next generation of gene and cell therapies using precision technology to target urgent and …See details»
Precigen, Inc. (PGEN): history, ownership, mission, how it works ...
Explore Precigen Inc.s mission, ownership, and business model. Learn how it generates revenue and sustains growth in the biotech field.See details»
Maximizing Value for Investors - Precigen
The Investor Relations website contains information about Precigen's business for stockholders, potential investors, and financial analysts.See details»
Science - Precigen
Precigen advances the promise of precision immunology through novel multifunctional gene and cell therapies designed to work in combination to achieve efficacy and safety.See details»
Precigen Reports Fourth Quarter and Full Year 2021 Financial Results
GERMANTOWN, Md., March 1, 2022 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell …See details»
Precigen, Inc. (PGEN) - Yahoo Finance
Find the latest Precigen, Inc. (PGEN) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Working At Precigen: Company Overview and Culture - Zippia
Find out what it's like to work at Precigen. See what kind of people work at Precigen, career paths working at Precigen, company culture, salaries, employee political affiliation, and more. …See details»
Precigen shares jump after US FDA approves first therapy for rare ...
Aug 15, 2025 Precigen's immunotherapy for a rare respiratory disease has become the first treatment to win U.S. regulatory approval for the condition, which typically requires frequent …See details»
Precigen Reports First Quarter 2025 Financial Results and Business ...
Mar 31, 2025 GERMANTOWN, Md., May 14, 2025 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and …See details»